Literature DB >> 25433198

Properties of polidocanol foam in view of its use in sclerotherapy.

V Nastasa1, K Samaras2, Ch Ampatzidis2, T D Karapantsios2, M A Trelles3, J Moreno-Moraga4, A Smarandache1, M L Pascu5.   

Abstract

Foam sclerotherapy is a widely used method to treat varicose veins disease. It is easy to use and apply, affordable, and has high efficiency that depends on foam stability upon injection. Since sclerotherapy is usually applied in a medical doctor's office, one of the most employed methods to generate foam is based on the Tessari technique which uses pumping cycles of liquid and air in-and-out of a double syringe system. Finally, the produced foam exits through a small orifice (∼2mm) at the output of a three-way valve. The present work shows results regarding the factors that may influence foam stability (liquid to air ratio, type of connector, syringe diameter, number of pumping cycles, etc.) of a commonly used sclerosing agent (polidocanol). Furthermore, an effort is made to evaluate the effect of adding different substances on the stability of polidocanol foams (0.5% w/w) by altering the surface tension or/and the bulk and interfacial rheological properties of the fluids. It is shown that adding small concentrations of nonionic surfactants can increase foam stability with just a very small variation of the mean bubbles size.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Foam stability; Glycerin (Pubchem CID 753); Polidocanol; Polidocanol (Pubchem CID 24750); Rheology; Sclerotherapy; Surfactant; Tween 80 (Pubchem CID 6364656); Xanthan gum (Pubchem CID 7107, CAS Registry Number: 11138-66-2)

Mesh:

Substances:

Year:  2014        PMID: 25433198     DOI: 10.1016/j.ijpharm.2014.11.056

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  7 in total

1.  In vitro and ex vivo evaluation of the biological performance of sclerosing foams.

Authors:  Elisabetta Bottaro; Jemma A J Paterson; Luciano Quercia; Xunli Zhang; Martyn Hill; Venisha A Patel; Stephen A Jones; Andrew L Lewis; Timothy M Millar; Dario Carugo
Journal:  Sci Rep       Date:  2019-07-08       Impact factor: 4.379

2.  Development of Glycerol-Rose Bengal-Polidocanol (GRP) foam for enhanced sclerosis of a cyst for cystic diseases.

Authors:  Soohyun Jeong; Sujin Kim; Youngjoo Choi; Han Na Jung; Kangwon Lee; Min Hee Park
Journal:  PLoS One       Date:  2021-01-05       Impact factor: 3.240

3.  Polidocanol foam sclerotherapy in the treatment of hemorrhoidal disease in patients with bleeding disorders: a multicenter, prospective, cohort study.

Authors:  P Salgueiro; A Rei; M Garrido; B Rosa; A M Oliveira; T Pereira-Guedes; S Morais; F Castro-Poças
Journal:  Tech Coloproctol       Date:  2022-02-25       Impact factor: 3.699

4.  The role of clinically-relevant parameters on the cohesiveness of sclerosing foams in a biomimetic vein model.

Authors:  Dario Carugo; Dyan N Ankrett; Vincent O'Byrne; David D I Wright; Andrew L Lewis; Martyn Hill; Xunli Zhang
Journal:  J Mater Sci Mater Med       Date:  2015-10-08       Impact factor: 3.896

5.  A modified Tessari method for producing more foam.

Authors:  Jie Xu; Yi-Fei Wang; An-Wei Chen; Tao Wang; Shao-Hua Liu
Journal:  Springerplus       Date:  2016-02-19

6.  Effect of Multiple Factors on Foam Stability in Foam Sclerotherapy.

Authors:  Taoping Bai; Wentao Jiang; Yu Chen; Fei Yan; Zhi Xu; Yubo Fan
Journal:  Sci Rep       Date:  2018-10-24       Impact factor: 4.379

Review 7.  Spectral Properties of Foams and Emulsions.

Authors:  Andra Dinache; Mihail-Lucian Pascu; Adriana Smarandache
Journal:  Molecules       Date:  2021-12-20       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.